Thane
08048093168
+918452805834

Development and Evaluation of Paediatric Dual-Layer Chewable Tablets Containing Paracetamol and Zinc

Research Article Published by Mr. Prashant Bhoir 
IDEAL COLLEGE OF PHARMACY AND RESEARCH
 ABSTRACT 
The present study aimed to develop and evaluate a paediatric dual-layer chewable tablet containing paracetamol and zinc sulphate to provide effective fever and pain management along with nutritional and immune support in children. Paediatric patients often experience difficulties swallowing conventional tablets, making chewable dosage forms a more convenient and acceptable alternative. The dual-layer design was selected to accommodate both active ingredients within a single dosage unit while maintaining formulation stability and improving patient compliance. Preformulation studies were conducted to assess the physicochemical properties of the active pharmaceutical ingredients and their compatibility with selected excipients. Fourier-transform infrared spectroscopy confirmed the absence of significant drug–excipient interactions. Powder blends were evaluated for flow and compression characteristics and demonstrated satisfactory bulk density, compressibility, and flowability suitable for direct compression. The tablets were formulated using microcrystalline cellulose, mannitol, crospovidone, aspartame, vanilla flavour, talc, and magnesium stearate. The prepared tablets were subjected to post-compression evaluation, including weight variation, thickness, hardness, friability, drug content uniformity, and dissolution testing. All quality parameters complied with pharmacopeial requirements. The optimized formulation exhibited adequate mechanical strength, excellent chewability, and acceptable organoleptic properties. In vitro dissolution studies revealed rapid drug release, with paracetamol and zinc sulphate releasing 94.6% and 97.1%, respectively, within 30 minutes. Accelerated stability studies conducted for three months demonstrated no significant changes in physical characteristics, drug content, or dissolution profile. The developed dual-layer chewable tablet represents a promising paediatric dosage form that combines therapeutic efficacy, improved palatability, enhanced patient compliance, and nutritional support in a single convenient formulation.
 2026-10-10T05:56:08

Keywords